Evolving Concepts of Type 2 Diabetes Management
| Autor: | Jane E.B. Reusch, Layla A Abushamat |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Patient characteristics Type 2 diabetes Comorbidity Hypoglycemia Glucagon-Like Peptide-1 Receptor Diabetes management Risk Factors Diabetes mellitus Medicine Humans Hypoglycemic Agents Insulin Social determinants of health Prospective Studies Renal Insufficiency Chronic Intensive care medicine Life Style Sodium-Glucose Transporter 2 Inhibitors Clinical Trials as Topic Dipeptidyl-Peptidase IV Inhibitors business.industry General Medicine medicine.disease Obesity Sulfonylurea Compounds Diabetes Mellitus Type 2 Cardiovascular Diseases Practice Guidelines as Topic Drug Therapy Combination Thiazolidinediones business Cardiorenal disease |
| Zdroj: | The Medical clinics of North America. 105(6) |
| ISSN: | 1557-9859 |
| Popis: | With the concept of patient-centered care in mind, this article outlines the current diabetes medications available for glucose lowering and the characteristics of each of these medications that need to be considered in shared decision-making for durable and effective therapy. Important patient characteristics such as weight, risk for hypoglycemia, cost, social determinants of health, and medical literacy need to be considered. The evidence-base informing the use of antihyperglycemic agents has changed dramatically due to 2008 FDA guidance for cardiovascular safety and cardiorenal protection with antihyperglycemic agents. New evidence supports an approach to diabetes management that addresses pre-existing cardiorenal disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|